Virax Biolabs announces 1-for-10 share consolidation

seekingalpha2023-12-14

Virax Biolabs (NASDAQ:VRAX) Thursday said its shareholders approved the proposed 1-for-10 share consolidation of its ordinary shares. The objective of the consolidation is to enable the company to ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2391571122?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-12-14 20:50","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2391571122","market":"us","top_or_hot":-1,"title":"Virax Biolabs announces 1-for-10 share consolidation","media":"seekingalpha","content":"<div>\n<p>Virax Biolabs (NASDAQ:VRAX) Thursday said its shareholders approved the proposed 1-for-10 share consolidation of its ordinary shares.\nThe objective of the consolidation is to enable the company to ...</p>\n\n<a href=\"https://seekingalpha.com/news/4046299-virax-biolabs-announces-1-for-10-share-consolidation\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Virax Biolabs announces 1-for-10 share consolidation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVirax Biolabs announces 1-for-10 share consolidation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-12-14 20:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4046299-virax-biolabs-announces-1-for-10-share-consolidation><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Virax Biolabs (NASDAQ:VRAX) Thursday said its shareholders approved the proposed 1-for-10 share consolidation of its ordinary shares.\nThe objective of the consolidation is to enable the company to ...</p>\n\n<a href=\"https://seekingalpha.com/news/4046299-virax-biolabs-announces-1-for-10-share-consolidation\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SQQQ","symbol_name":"纳指三倍做空ETF","start_time":0,"source_url":"https://seekingalpha.com/news/4046299-virax-biolabs-announces-1-for-10-share-consolidation","article_id":"2391571122","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2391571122","pubTimestamp":1702558213,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Virax Biolabs  Thursday said its shareholders approved the proposed 1-for-10 share consolidation of its ordinary shares.The objective of the consolidation is to enable the company to regain compliance with Nasdaq Marketplace Rule 5550 and maintain its listing on the Nasdaq Capital Market.Beginning with the opening of trading on Dec. 18, the company's shares will begin trading on a post-share consolidation basis on the Nasdaq. Source: Press Release. More on Virax Biolabs Group Limited  Seeking Alpha’s Quant Rating on Virax Biolabs Group Limited Historical earnings data for Virax Biolabs Group Limited Financial information for Virax Biolabs Group Limited","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"SQQQ":"纳指三倍做空ETF","TQQQ":"纳指三倍做多ETF",".IXIC":"NASDAQ Composite","BK4583":"猴痘概念","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","BK4175":"保健护理产品经销商","PSQ":"纳指反向ETF","VRAX":"Virax Biolabs Group Limited","QID":"纳指两倍做空ETF"},"translate_title":"Virax Biolabs宣布1比10的股份合并","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VRAX":1,".IXIC":0.9,"MNQmain":0.6,"NQmain":0.6,"PSQ":0.6,"QID":0.6,"QLD":0.6,"QQQ":0.6,"SQQQ":0.6,"TQQQ":0.6},"content_text":"Virax Biolabs (NASDAQ:VRAX) Thursday said its shareholders approved the proposed 1-for-10 share consolidation of its ordinary shares.\nThe objective of the consolidation is to enable the company to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) and maintain its listing on the Nasdaq Capital Market.\nBeginning with the opening of trading on Dec. 18, the company's shares will begin trading on a post-share consolidation basis on the Nasdaq. Source: Press Release\n\n\n\nMore on Virax Biolabs Group Limited  Seeking Alpha’s Quant Rating on Virax Biolabs Group Limited Historical earnings data for Virax Biolabs Group Limited Financial information for Virax Biolabs Group Limited","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.0","shortVersion":"4.24.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2391571122"}